|
Market Closed -
Euronext Paris
19:55:00 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 22.00 EUR | 0.00% |
|
0.00% | -8.33% |
| 09-04 | Bastide Le Confort Medical: FY sales beat guidance - end of coverage on 1st of October |  |
| 09-03 | Bastide Group reaffirms its operating margin target for the fiscal year |  |
Company Valuation: Bastide Le Confort Médical
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 347 | 258 | 208.9 | 134.1 | 232.1 | 163.1 | - | - |
| Change | - | -25.65% | -19.05% | -35.8% | 73.08% | -29.74% | - | - |
| Enterprise Value (EV) 1 | 670.9 | 655.1 | 523.4 | 449.3 | 623 | 412.1 | 411.1 | 409.1 |
| Change | - | -2.36% | -20.1% | -14.16% | 38.66% | -33.86% | -0.24% | -0.49% |
| P/E | 26x | 19x | 18.8x | -151x | 447x | 12.9x | 12.8x | 10.4x |
| PBR | 4.29x | 3.04x | 2.43x | 1.69x | 3.44x | - | - | - |
| PEG | - | 11.59x | -1x | 1x | -3x | 0x | 10.88x | 0.5x |
| Capitalization / Revenue | 0.78x | 0.55x | 0.41x | 0.25x | 0.47x | 0.32x | 0.33x | 0.31x |
| EV / Revenue | 1.51x | 1.4x | 1.03x | 0.85x | 1.27x | 0.81x | 0.82x | 0.77x |
| EV / EBITDA | 7.6x | 6.9x | 5.15x | 4.18x | 5.98x | 3.87x | 3.93x | 3.67x |
| EV / EBIT | 18.1x | 16.8x | 12.2x | 10x | 14.1x | 8.92x | 9.07x | 8.49x |
| EV / FCF | 24.1x | 183x | 10.1x | 12x | 14.9x | 17.2x | 16.3x | 15.9x |
| FCF Yield | 4.15% | 0.55% | 9.94% | 8.3% | 6.7% | 5.82% | 6.13% | 6.31% |
| Dividend per Share 2 | 0.27 | - | - | - | - | - | - | - |
| Rate of return | 0.57% | - | - | - | - | - | - | - |
| EPS 2 | 1.83 | 1.86 | 1.52 | -0.12 | 0.07 | 1.7 | 1.72 | 2.11 |
| Distribution rate | 14.8% | - | - | - | - | - | - | - |
| Net sales 1 | 444.1 | 468.3 | 508 | 529.8 | 491.2 | 507 | 499 | 528 |
| EBITDA 1 | 88.3 | 95 | 101.6 | 107.6 | 104.2 | 106.6 | 104.7 | 111.5 |
| EBIT 1 | 36.98 | 38.9 | 42.79 | 44.9 | 44.2 | 46.2 | 45.3 | 48.2 |
| Net income 1 | 13.45 | 13.68 | 12.05 | -0.9 | 0.528 | 12.7 | 12.9 | 15.8 |
| Net Debt 1 | 323.9 | 397.1 | 314.6 | 315.2 | 390.9 | 249 | 248 | 246 |
| Reference price 2 | 47.50 | 35.30 | 28.60 | 18.10 | 31.30 | 22.00 | 22.00 | 22.00 |
| Nbr of stocks (in thousands) | 7,306 | 7,309 | 7,303 | 7,408 | 7,415 | 7,412 | - | - |
| Announcement Date | 18/10/21 | 18/10/22 | 18/10/23 | 23/10/24 | 22/10/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 12.94x | 0.81x | 3.87x | -.--% | 190M | |
| 37.39x | 0.93x | 17.06x | -.--% | 12.66B | |
| 19.27x | 1.34x | 10.39x | -.--% | 2.17B | |
| 33.48x | - | - | - | 1.33B | |
| 8.9x | 0.92x | 4.84x | 5.33% | 75.14M | |
| Average | 22.40x | 1.00x | 9.04x | 1.33% | 3.28B | |
| Weighted average by Cap. | 34.26x | 0.99x | 15.87x | 0.03% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BLC Stock
- Valuation Bastide Le Confort Médical
Select your edition
All financial news and data tailored to specific country editions
